{
  "id": 1736073,
  "title": "Leo Pharma buys rare skin disease drug in $435M deal",
  "url": "https://urgent.news/2026/08/18/leo-pharma-buys-rare-skin-disease-drug-in-435m-deal",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-18T14:38:00.000Z",
  "source": {
    "name": "BioPharma Dive",
    "slug": "biopharma-dive",
    "url": "https://www.biopharmadive.com/news/leo-pharma-buys-late-stage-skin-disease-drug-435m-deal/828150/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Tanabe Pharma has already asked the FDA to approve the medicine for two conditions that cause severe reactions to sunlight.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Endpoints News",
        "title": "Leo Pharma to license Tanabe’s rare disease drug for pain with sun exposure",
        "url": "https://urgent.news/2026/08/18/leo-pharma-to-license-tanabes-rare-disease-drug-for-pain-with-sun",
        "published": "2026-08-18T07:00:16.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}